Exosome Diagnostics Launches CLIA-Certified Laboratory

August 12, 2015 Leave a comment

Company centralizing U.S. operations ahead of cancer liquid biopsy test launches in 2015 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced that it has opened a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in Cambridge, ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Clinical Laboratory Improvement Amendments

Exosome Diagnostics Launches CLIA-Certified Laboratory

Researchers have succeeded for the first time in analyzing nanovesicles and proteins in parallel

FDA grants breakthrough device designation for Biological Dynamics’ exosome-based early-stage pancreatic cancer detection test

Diabetes complications and extracellular vesicle therapy

Smart exosomes with lymph node homing and immune amplifying capacities for enhanced immunotherapy of metastatic breast cancer

Mursla Granted Patent for Novel Nanoelectronics Detection System for Exosomes

The genetic source tracking of human urinary exosomes